Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)

DEVICE2 trials

Sponsors

Mitralign, Inc.

Conditions

Chronic Symptomatic Functional Tricuspid RegurgitationHeart Valve DiseaseTricuspid Valve Insufficiency

Unknown Phase

Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.

Mitralign, Inc.Chronic Symptomatic Functional Tricuspid Regurgitation, Heart Valve Disease, Tricuspid Valve Insufficiency

Start: 2015-11-30End: 2019-05-31Target: 30Updated: 2017-10-27

Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)

Mitralign, Inc.Chronic Symptomatic Functional Tricuspid Regurgitation, Heart Valve Disease, Tricuspid Valve Insufficiency

Start: 2017-05-22End: 2022-11-30Target: 60Updated: 2018-02-07

Related Papers

Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty: SCOUT Trial 30-Day Results.

2017-04-01202 citations